Lysine

Lysine

SCHEMBL3312740

C[N+](C)(C)CCO.Cl.NCCCC[C@H](N)C(=O)O.[Cl-]

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.62
▸ ARG2 P78540 4/20 0.44
▸ NOS2 P35228 5/20 0.43
▸ NOS1 P29475 4/20 0.43
▸ BLM P54132 1/20 0.43
▸ ARG1 P05089 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ SLC5A7 Q9GZV3 1/20 0.41
▸ NOS3 P29474 3/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ RNPEP Q9H4A4 1/20 0.40
▸ MEN1 O00255 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL3312731 1.00 GSR (0.62) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL28275584 0.98 GSR (0.65) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL7113294 0.97 GSR (0.67) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL20530995 0.97 GSR (0.67) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL7113285 0.97 GSR (0.67) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL28189328 0.93 GSR (0.57) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL28189329 0.93 GSR (0.57) GSRARG2NOS2NOS1BLM
Ornithine Aketoglutarate SCHEMBL29232510 0.92 GSR (0.58) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL29066022 0.91 GSR (0.56) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL28084777 0.89 GSR (0.53) GSRARG2NOS2NOS1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9717693-B2 Compositions of microparticles and granules for oral controlled release of substances for veterinary use KEMIN INDUSTRIES, INC. (US) 2017-08-01 — — US disclosed
US-20100112075-A1 COMPOSITIONS OF MICROPARTICLES AND GRANULES FOR ORAL CONTROLLED RELEASE OF SUBSTANCES FOR VETERINARY USE EURHEMA S.R.I. (IT) 2010-05-06 — — US disclosed
Send feedback